These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31173881)

  • 1. Assessment of ctDNA in CSF may be a more rapid means of assessing surgical outcomes than plasma ctDNA in glioblastoma.
    Li JH; He ZQ; Lin FH; Chen ZH; Yang SY; Duan H; Jiang XB; Al-Nahari F; Zhang XH; Wang JH; Zhang GH; Zhang ZF; Li C; Mou YG
    Mol Cell Probes; 2019 Aug; 46():101411. PubMed ID: 31173881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
    Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
    Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients.
    Guo W; Jin L; Liang J; Lin G; Zheng J; Zhou D; Zhan S; Sun H; Jiang X
    Clin Chim Acta; 2022 Sep; 534():81-92. PubMed ID: 35810802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.
    Bagley SJ; Nabavizadeh SA; Mays JJ; Till JE; Ware JB; Levy S; Sarchiapone W; Hussain J; Prior T; Guiry S; Christensen T; Yee SS; Nasrallah MP; Morrissette JJD; Binder ZA; O'Rourke DM; Cucchiara AJ; Brem S; Desai AS; Carpenter EL
    Clin Cancer Res; 2020 Jan; 26(2):397-407. PubMed ID: 31666247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.
    Zhao Z; Zhang C; Li M; Shen Y; Feng S; Liu J; Li F; Hou L; Chen Z; Jiang J; Ma X; Chen L; Yu X
    Jpn J Clin Oncol; 2020 Mar; 50(3):325-332. PubMed ID: 32039443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma.
    Duan H; Hu JL; Chen ZH; Li JH; He ZQ; Wang ZN; Zhang GH; Guo XY; Liang L; Mou YG
    Chin Med J (Engl); 2020 Jun; 133(12):1415-1421. PubMed ID: 32558704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses in non-small cell lung cancer patients with brain metastases: a prospective cohort study (GASTO 1028).
    Li M; Chen J; Zhang B; Yu J; Wang N; Li D; Shao Y; Zhu D; Liang C; Ma Y; Ou Q; Hou X; Chen L
    BMC Med; 2022 Nov; 20(1):398. PubMed ID: 36372873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
    Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
    BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors.
    Hickman RA; Miller AM; Holle BM; Jee J; Liu SY; Ross D; Yu H; Riely GJ; Ombres C; Gewirtz AN; Reiner AS; Nandakumar S; Price A; Kaley TJ; Graham MS; Vanderbilt C; Rana S; Hill K; Chabot K; Campos C; Nafa K; Shukla N; Karajannis M; Li B; Berger M; Ladanyi M; Pentsova E; Boire A; Brannon AR; Bale T; Mellinghoff IK; Arcila ME
    Acta Neuropathol Commun; 2024 Sep; 12(1):151. PubMed ID: 39289779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of tumor in situ fluid circulating tumor DNA in recurrent glioblastomas forecasts treatment efficacy of immune checkpoint blockade coupled with low-dose bevacizumab.
    Wang D; Zhang J; Bu C; Liu G; Guo G; Zhang Z; Lv G; Sheng Z; Yan Z; Gao Y; Wang M; Liu G; Zhao R; Li T; Ma C; Bu X
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):466. PubMed ID: 39422764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
    Yamauchi M; Urabe Y; Ono A; Miki D; Ochi H; Chayama K
    Int J Cancer; 2018 Apr; 142(7):1418-1426. PubMed ID: 29134647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA.
    Pan C; Diplas BH; Chen X; Wu Y; Xiao X; Jiang L; Geng Y; Xu C; Sun Y; Zhang P; Wu W; Wang Y; Wu Z; Zhang J; Jiao Y; Yan H; Zhang L
    Acta Neuropathol; 2019 Feb; 137(2):297-306. PubMed ID: 30460397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models.
    Mair R; Mouliere F; Smith CG; Chandrananda D; Gale D; Marass F; Tsui DWY; Massie CE; Wright AJ; Watts C; Rosenfeld N; Brindle KM
    Cancer Res; 2019 Jan; 79(1):220-230. PubMed ID: 30389699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
    Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC.
    Wu J; Liu Z; Huang T; Wang Y; Song MM; Song T; Long G; Zhang X; Li X; Zhang L
    Mol Oncol; 2023 May; 17(5):810-824. PubMed ID: 36495130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors.
    Piccioni DE; Achrol AS; Kiedrowski LA; Banks KC; Boucher N; Barkhoudarian G; Kelly DF; Juarez T; Lanman RB; Raymond VM; Nguyen M; Truong JD; Heng A; Gill J; Saria M; Pingle SC; Kesari S
    CNS Oncol; 2019 Jun; 8(2):CNS34. PubMed ID: 30855176
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.
    Fontanilles M; Deniel A; Marguet F; Beaussire L; Magne N; Derrey S; Blanchard F; Alexandru C; Coutant S; Laquerrière A; Clatot F; Di Fiore F; Sarafan-Vasseur N
    Rev Neurol (Paris); 2022 Nov; 178(9):975-980. PubMed ID: 35871016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance analysis of cerebrospinal fluid with the tumor tissue for integrated diagnosis in gliomas based on next-generation sequencing.
    Wang Q; Liang Q; Wei W; Niu W; Liang C; Wang X; Wang X; Pan H
    Pathol Oncol Res; 2023; 29():1611391. PubMed ID: 37822669
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.
    Ronsley R; Karvonen KA; Cole B; Paulson V; Stevens J; Crotty EE; Hauptman J; Lee A; Stasi SM; Lockwood CM; Leary SES
    J Neurooncol; 2024 Jun; 168(2):215-224. PubMed ID: 38755519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.